Our findings further implicate adiponectin dysfunction in diabetes and diabetic kidney disease and link abnormalites in circulating adiponectin with elevated ceramide levels through impaired activation of its cognate receptors. This evidence concerns the gene ADIPOQ and diabetic kidney disease.